Commercialization and Prototype Development
Elisa Kit Development – BioMark has successfully developed Elisa kits using antibodies generated at UBC’s Biomedical Research Centre by Dr. Schrader and his team. The kits were developed under CLSI specifications and are under key customer test site. Double blinded study was also designed to ensure the reliability of the test kits Point Of Care […]
New Scientific Advisory Board
BioMark would like to introduce and welcome 2 new members to its scientific advisory board. The new members are: Dr. Samudra Dissanayake, Director Strategic Initiatives and Business Development Health-Tech-Connex Dr. Dissanayake has been an important contributor in the development of BioMark’s technology platform for cancer screening, response to treatment and cancer treatment. Dr. Dissanayake role […]